These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 11528)

  • 21. The effects of psychomotor stimulants on single-spatial alternation behavior in dogs.
    Risner ME; Jones BE
    Psychopharmacology (Berl); 1979 May; 63(2):137-41. PubMed ID: 38475
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of CYP2D1 inhibition on the behavioural effects of d-amphetamine.
    Tomkins DM; Otton SV; Joharchi N; Berns T; Wu D; Corrigall WA; Sellers EM
    Behav Pharmacol; 1997 Jun; 8(2-3):223-35. PubMed ID: 9833017
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of propranolol, d-amphetamine and caffeine on ethanol as a discriminative cue.
    Schechter MD
    Eur J Pharmacol; 1974 Nov; 29(1):52-7. PubMed ID: 4435044
    [No Abstract]   [Full Text] [Related]  

  • 24. Neurochemical consequences following administration of CNS stimulants to the neonatal rat.
    Wagner GC; Schuster CR; Seiden LS
    Pharmacol Biochem Behav; 1981 Jan; 14(1):117-9. PubMed ID: 6110209
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Psychomotor stimulants, social deprivation and play in juvenile rats.
    Beatty WW; Dodge AM; Dodge LJ; White K; Panksepp J
    Pharmacol Biochem Behav; 1982 Mar; 16(3):417-22. PubMed ID: 6123118
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Discriminative stimulus properties of cocaine and d-amphetamine, and antagonism by haloperidol: a comparative study.
    Colpaert FC; Niemegeers CJ; Janssen PA
    Neuropharmacology; 1978 Nov; 17(11):937-42. PubMed ID: 724101
    [No Abstract]   [Full Text] [Related]  

  • 27. Avoidance acquisition and CNS stimulants.
    Kulkarni AS
    Naunyn Schmiedebergs Arch Pharmacol; 1972; 273(4):394-400. PubMed ID: 4403235
    [No Abstract]   [Full Text] [Related]  

  • 28. Absence of effect of stimulants on the phamacokinetics of desipramine in children.
    Cohen LG; Prince J; Biederman J; Wilens T; Faraone SV; Whitt S; Mick E; Spencer T; Meyer MC; Polisner D; Flood JG
    Pharmacotherapy; 1999 Jun; 19(6):746-52. PubMed ID: 10391421
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stimulant sensitization in humans.
    Gorelick DA; Rothman RB
    Biol Psychiatry; 1997 Aug; 42(3):230-1. PubMed ID: 9232217
    [No Abstract]   [Full Text] [Related]  

  • 30. A comparison of the effects of cocaine and synthetic central stimulants.
    Bejerot N
    Br J Addict Alcohol Other Drugs; 1970 May; 65(1):35-7. PubMed ID: 5270374
    [No Abstract]   [Full Text] [Related]  

  • 31. Interactions between depressants (alcohol-type) and stimulants (amphetamine-type).
    Rech RH; Vomachka MK; Rickert DE
    Pharmacol Biochem Behav; 1978 Feb; 8(2):143-51. PubMed ID: 652824
    [No Abstract]   [Full Text] [Related]  

  • 32. The evaluation of central nervous system stimulants in a new laboratory test for antidepressants.
    Sanghvi I; Gershon S
    Life Sci; 1969 May; 8(9):449-57. PubMed ID: 4389344
    [No Abstract]   [Full Text] [Related]  

  • 33. Effects of amphetamine, methylphenidate and cocaine on serum prolactin concentrations in the male rat.
    Ravitz AJ; Moore KE
    Life Sci; 1977 Jul; 21(2):267-72. PubMed ID: 886924
    [No Abstract]   [Full Text] [Related]  

  • 34. Peak-potentialities of inspiratory musculature as disclosed by tracheal occlusion.
    Bucher K; Benz-Lippold M; Bättig P
    Agents Actions; 1973 May; 3(1):28-34. PubMed ID: 4146022
    [No Abstract]   [Full Text] [Related]  

  • 35. A novel tremorigen antagonized by D-amphetamine.
    Banna NR; Kurkjian R
    Brain Res; 1975 Apr; 87(1):114-7. PubMed ID: 1120249
    [No Abstract]   [Full Text] [Related]  

  • 36. Tissue concentrations and the mortality of d-amphetamine in mice: changes associated with the use of diethylaminoethyl 2,2-diphenylvalerate.HCl1.
    James RC; Franklin MR
    Toxicol Appl Pharmacol; 1978 Apr; 44(1):75-80. PubMed ID: 675695
    [No Abstract]   [Full Text] [Related]  

  • 37. The novel triple reuptake inhibitor JZAD-IV-22 exhibits an antidepressant pharmacological profile without locomotor stimulant or sensitization properties.
    Caldarone BJ; Paterson NE; Zhou J; Brunner D; Kozikowski AP; Westphal KG; Korte-Bouws GA; Prins J; Korte SM; Olivier B; Ghavami A
    J Pharmacol Exp Ther; 2010 Dec; 335(3):762-70. PubMed ID: 20864506
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Psychostimulant-like discriminative stimulus and locomotor sensitization properties of the wake-promoting agent modafinil in rodents.
    Paterson NE; Fedolak A; Olivier B; Hanania T; Ghavami A; Caldarone B
    Pharmacol Biochem Behav; 2010 Jun; 95(4):449-56. PubMed ID: 20346966
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cocaine as a discriminative cue in rats: interactions with neuroleptics and other drugs.
    Järbe TU
    Psychopharmacology (Berl); 1978 Oct; 59(2):183-7. PubMed ID: 31651
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Discriminative response control by psychomotor stimulants.
    Silverman PB; Ho BT
    Psychopharmacol Commun; 1976; 2(4):331-7. PubMed ID: 11528
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.